FactorPad
Build a Better Process

Stock Risk Measures for Halozyme Therapeutics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 43 for HALO below.

/ factorpad.com / stocks / f68xng.html


An ad-free and cookie-free webpage by FactorPad


HALO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Halozyme Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how HALO stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f68xng.html


HALO stock risk
HALOZYME THERAPEUTICS INC stock beta
HALO risk report
HALO f68xng
HALO risk analysis
HALO volatility
HALOZYME THERAPEUTICS INC credit risk
HALO liquidity risk
HALO leverage
HALO valuation
HALO systematic risk
HALO specific risk
HALOZYME THERAPEUTICS INC volatility
HALO analysis
HALO financial ratio

This is a new resource, spread the word, tell a friend